Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413498
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-05-09
Brief Title:
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed Refractory Multiple Myeloma
Sponsor:
Kite A Gilead Company
Organization:
Gilead Sciences